Sutton Wealth Advisors Inc. Vir Biotechnology, Inc. Transaction History

Sutton Wealth Advisors Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Nov 07, 2023	SELL	$22.26 - $30.85 $28,181 - $39,056	-1,266 Closed	0 $0
Q4 2022 Nov 07, 2023	BUY	$19.96 - $28.22 $12,015 - $16,988	602 Added 90.66%	1,266 $32 Million
Q3 2022 Nov 07, 2023	SELL	$18.26 - $31.1 $15,210 - $25,906	-833 Reduced 55.64%	664 $12.8 Million
Q2 2022 Nov 07, 2023	BUY	$19.08 - $26.7 $28,562 - $39,969	1,497 New	1,497 $38.1 Million

219

87.4M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $922M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.